Ledger.Open graph →
SEC Form D · filed December 4, 2013

VenatoRx Pharmaceuticals, Inc

Offering
$4.0M
Sold
$3.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
MALVERN, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Gregg Johnson · Santa Barbara, CAExec · DirectorLuigi J. Xerri · Malvern, PAExec · DirectorSteven Frankel · New York, NYDirectorMark Suster · Santa Barbara, CAExec · DirectorWilliam O'Halloran · Boston, MAExec · DirectorNicholas A. Sinatra · Buffalo, NYExec · DirectorPatrick Finucane · Buffalo, NYDirectorAdam Fuller · Atlanta, GAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗